u/pavel_kravchenko

Disagree — that is your province’s formulary position and it does not carry to another.

That reads as a recommendation and the source pages deliberately are not. They are a record you use to make your own decision.

Fertility can change with weight loss and improved insulin sensitivity. That is a well-described phenomenon and worth knowing about in advance rather than discovering.

A certificate with a purity figure and no method line is not falsifiable. You cannot reproduce it, you cannot check it, and it tells you nothing about how the number was produced.

Has anyone posted an independent result on that batch?

The scheme cap in Ireland was the single most useful thing I learned in a year of reading this board.

ask the pharmacy what the cash price is, it varies

Small fix — that formulary position is another province’s and does not apply here.

Formulary criteria are revised, and plan renewal is a natural point at which a previously refused request may succeed without anything about the applicant changing.

Correction: that study was in rodents. Worth stating explicitly since the thread has been reading it as clinical.

That is a purity figure, not an identity confirmation. Two different tests and only one answers the question asked.

Nothing in this thread is medical advice, and the choice between arrangements is one for you and a prescriber who knows your history.

Kept the same programme for a year instead of changing it every six weeks. That was the change that worked.

Correction: that is regulatory approval, not coverage. They are separate decisions by separate bodies.

Was there potency testing on the finished preparation, or only on the starting material?

the wider-market names in the table are there because nobody has enough data on them

the interesting column is spread, not maximum

if a clinic will not name the facility, that is your answer

Concentrations can differ between products and between pharmacies.

Agreed — and keeping the letters with dates is what makes any later challenge possible.

Research-use-only material is not approved for human use. That is a plain statement of regulatory fact and it belongs in every beginner thread.

Discharge from a specialist service at goal is a normal end point of that pathway. Whether prescribing continues in primary care afterwards is a local decision and is worth asking about at the start rather than at the end.

That claim traces back to a single preclinical paper that says something considerably narrower.

Same. Volume over novelty. Changing programme every six weeks cost me a year.

Nothing in this thread is medical advice, and the choice between arrangements is one for you and a prescriber who knows your history.

Nothing on this board is medical advice, and the people answering you — including me — are members with spreadsheets rather than clinicians.

keep every form, every date, every reference number

Fixing my own comment above: I said 20 orders and it is 8. The pattern is the same, the count was wrong.

Did the lot code on the vial match the paperwork?

GP said no in the spring, specialist said yes eighteen months later. Same person, same numbers.

Yes. Spread across lots is the number that tells you about the process. A single high result tells you about a vial.

Agreed that the vocabulary here is imprecise and it causes people to answer different questions to the ones asked.

Do you have the mass spectrum?

the Irish scheme cap is the single most useful fact in this board

Careful. "Nobody has tested Core Peptides" is a statement about this board, not about the supplier. Say the first thing, not the second.

Careful, that pricing figure is a headline offer with conditions attached rather than the actual monthly cost.

Wrote the concentration on the vial after reading it here. Have never once had to reconstruct it from memory since.

Disagree — that is your province’s formulary position and it does not carry to another.

Correction: the starting dose is a tolerance step rather than a treatment dose. The distinction is the answer to the question above.